BR9913175A - Fosfoglicolipìdios e métodos para seu uso - Google Patents

Fosfoglicolipìdios e métodos para seu uso

Info

Publication number
BR9913175A
BR9913175A BR9913175-7A BR9913175A BR9913175A BR 9913175 A BR9913175 A BR 9913175A BR 9913175 A BR9913175 A BR 9913175A BR 9913175 A BR9913175 A BR 9913175A
Authority
BR
Brazil
Prior art keywords
methods
compound
reperfusion
deoxy
ischemia
Prior art date
Application number
BR9913175-7A
Other languages
English (en)
Inventor
Gary T Elliot
Patricia A Weber
C Gregory Sowell
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of BR9913175A publication Critical patent/BR9913175A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: <B>"FOSFOGLICOLIPìDIOS E MéTODOS PARA SEU USO"<D>. A invenção diz respeito a um novo composto de fosfoglicolipídio. O composto do objeto da invenção é 2-Deóxi-6-O- [2-deóxi-4-O - fosfono-3-O -[(R)-3- tetradecanoiloxitetradecanoila] -2-[(R)-3- octadecanoiloxitetradecanoilamino] -ß-D-glucopiranosila] -2-[(R)-3- hexadecanoiloxitetradecanoilamino] -D-glucopiranose e sais aceitáveis farmaceuticamente disso. O composto não é imunoreativo, nem pirogênico, nem tóxico mas é ativo em melhorar dano do tecido devido a prejuízo de isquemia/reperfusão. Métodos para usar o sujeito composto para proteger contra dano reversível e irreversível devido a prejuízo de isquemia/reperfusão são também revelados.
BR9913175-7A 1998-08-21 1999-08-18 Fosfoglicolipìdios e métodos para seu uso BR9913175A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/138,305 US6013640A (en) 1998-08-21 1998-08-21 Phosphoglycolipid and methods for its use
PCT/US1999/019063 WO2000011010A1 (en) 1998-08-21 1999-08-18 Phosphoglycolipid and methods for its use

Publications (1)

Publication Number Publication Date
BR9913175A true BR9913175A (pt) 2001-10-09

Family

ID=22481436

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913175-7A BR9913175A (pt) 1998-08-21 1999-08-18 Fosfoglicolipìdios e métodos para seu uso

Country Status (19)

Country Link
US (2) US6013640A (pt)
EP (1) EP1105401B1 (pt)
JP (1) JP2002523420A (pt)
KR (1) KR20010072806A (pt)
CN (1) CN1324364A (pt)
AT (1) ATE263776T1 (pt)
AU (1) AU754186B2 (pt)
BR (1) BR9913175A (pt)
CA (1) CA2340649A1 (pt)
CZ (1) CZ2001637A3 (pt)
DE (1) DE69916289D1 (pt)
HU (1) HUP0103473A3 (pt)
ID (1) ID28984A (pt)
IL (1) IL141496A0 (pt)
NO (1) NO20010854L (pt)
NZ (1) NZ510260A (pt)
PL (1) PL349422A1 (pt)
TR (1) TR200100636T2 (pt)
WO (1) WO2000011010A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
PL206832B1 (pl) 2000-05-19 2010-09-30 Corixa Corp Zastosowanie związków opartych na mono- i disacharydach
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US7129219B2 (en) * 2000-08-04 2006-10-31 Corixa Corporation Immunoeffector compounds
US7759803B2 (en) * 2001-07-25 2010-07-20 Rohm Co., Ltd. Semiconductor device and method of manufacturing the same
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
JP2005516980A (ja) * 2002-02-04 2005-06-09 コリクサ コーポレイション 新規な免疫エフェクター化合物
US6911434B2 (en) 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
US7288640B2 (en) * 2002-07-08 2007-10-30 Corixa Corporation Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
IL166178A0 (en) * 2002-07-08 2006-01-15 Corixa Corp Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor
US20050152835A1 (en) * 2003-10-31 2005-07-14 Pak Koon Y. Technetium-99M glucarate methods of use for monitoring tissues
WO2006107107A1 (ja) * 2005-04-01 2006-10-12 Fumitaka Ohsuzu リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法
WO2008018932A2 (en) 2006-05-01 2008-02-14 The Board Of Trustees Of The Leland Stanford Junior University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
BRPI0721393B8 (pt) * 2007-03-22 2022-09-06 Fund Butantan método para obter lipídeo a monofosforilado da bordetella pertussis como um subproduto da produção de vacina celular contra coqueluche
BRPI0911195A2 (pt) * 2008-04-09 2017-06-20 The Univ Of North Caroline At Chapel Hill métodos de regulação de arranjo de citoesqueleto de actina e formação de gap intracelular

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5286718A (en) * 1991-12-31 1994-02-15 Ribi Immunochem Research, Inc. Method and composition for ameliorating tissue damage due to ischemia and reperfusion
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents

Also Published As

Publication number Publication date
JP2002523420A (ja) 2002-07-30
EP1105401A1 (en) 2001-06-13
CZ2001637A3 (cs) 2001-10-17
NO20010854L (no) 2001-04-20
AU5683299A (en) 2000-03-14
IL141496A0 (en) 2002-03-10
CA2340649A1 (en) 2000-03-02
EP1105401B1 (en) 2004-04-07
NZ510260A (en) 2002-10-25
ID28984A (id) 2001-07-19
CN1324364A (zh) 2001-11-28
DE69916289D1 (de) 2004-05-13
ATE263776T1 (de) 2004-04-15
NO20010854D0 (no) 2001-02-20
HUP0103473A2 (hu) 2002-04-29
AU754186B2 (en) 2002-11-07
US6013640A (en) 2000-01-11
KR20010072806A (ko) 2001-07-31
TR200100636T2 (tr) 2002-02-21
PL349422A1 (en) 2002-07-29
US20020013291A1 (en) 2002-01-31
WO2000011010A1 (en) 2000-03-02
US6399590B2 (en) 2002-06-04
HUP0103473A3 (en) 2003-01-28

Similar Documents

Publication Publication Date Title
BR9913175A (pt) Fosfoglicolipìdios e métodos para seu uso
NO2016024I1 (no) Farmasøytisk blanding eller assosisjon som inneholder som aktive ingredienser: (1) ceftazidim eller et salt derav, og (2) avibaktam eller et farmasøytisk akseptabelt salt derav
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
HUP0203330A2 (hu) Benzamidszármazékot tartalmazó javított oldhatóságú és orális felszívódású gyógyszerkészítmények
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
BRPI9810519A (pt) derivados de 4&#39;&#39;-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
BRPI9914741A (pt) n-(2-aril-proprionil)-sulfonamidas, usos e composições farmacêuticas contendo as mesmas.
NO20004550L (no) Enzyminhibitorer
RS50173B (sr) Upotreba epinastina za lečenje alergijskog rinitisa/konjuktivitisa
BR9914940A (pt) Método para aperfeiçoar a farmacocinética de tipranavir
BRPI0408136A (pt) derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda
BRPI0408295A (pt) uso de um composto
BR0016831A (pt) Composição terapêutica e lente de contato impregnada pela mesma
SE0103528D0 (sv) Topiska kompositioner med förstärkt effekt
ES2104938T3 (es) Metodo de inhibir la fibrosis.
GT199900171A (es) Concentrado oral de sertralina.
HUP9701293A2 (hu) Új, kellemetlen íztől mentes sók és ezeket tartalmazó gyógyszerkészítmények
HUP0102075A2 (hu) Stabil mitoxantron-oldatok, eljárás az előállításukra
IT1306147B1 (it) Derivati di principi attivi ad attivita&#39; terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları
SE9802538D0 (sv) New pharmaceutically active compounds
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
DK1680067T3 (da) Sammensætning til kosmetisk behandling af aldersrelaterede dermatologiske symptomer
BR0309055A (pt) Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4 A 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.